| Description | 1. Fargesin ((+/-)-Fargesin) as a potential β1AR antagonist through cAMP/PKA pathway could protect against myocardial ischemia/reperfusion injury in rats. 2. Fargesin improves dyslipidemia and hyperglycemia by activating Akt and AMPK in WAT. |
| Synonyms | 辛夷脂素, (+/-)-Fargesin |
| molecular weight | 370.4 |
| Molecular formula | C21H22O6 |
| CAS | 31008-19-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 33 mg/mL(89.1 mM) Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble |
| References | 1. Wang X , Cheng Y , Xue H , et al. Fargesin as a potential β₁ adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis.[J]. Fitoterapia, 2015, 105:16-25. |